Generic placeholder image

Current Biochemical Engineering (Discontinued)

Editor-in-Chief

ISSN (Print): 2212-7119
ISSN (Online): 2212-7127

Editorial

Bioactive-Loaded Chemical Engineered Nanocarriers for Health Care Applications

Author(s): Mahfoozur Rahman, Sarwar Beg and Imran Kazmi

Volume 6 , Issue 1 , 2020

Page: [5 - 6] Pages: 2

DOI: 10.2174/221271190601200312100347

[1]
K.O. Anderson, L.A. Bradley, L.D. Young, L.K. McDaniel, and C.M. Wise, "Rheumatoid arthritis: Review of psychological factors related to etiology, effects, and treatment", Psychol. Bull., vol. 98, pp. 358-387, 1985.
[2]
M. Rahman, V. Kumar, S. Beg, G. Sharma, O.P. Katare, and F. Anwar, "Emergence of liposome as targeted magic bullet for inflammatory disorders: Current state of the art", Artif. Cells Nanomed. Biotechnol., vol. 13, pp. 1-12, 2016.
[3]
J. Albuquerque, C.C. Moura, B. Sarmento, and S. Reis, "Solid lipid nanoparticles: A potential multifunctional approach towards rheumatoid arthritistheranostics", Molecules, vol. 20, pp. 11103-11118, 2015.
[4]
M.Z. Siddiqui, "Boswellia serrata, apotential anti-inflammatory agent: An overview", Indian J. Pharm. Sci., vol. 73, pp. 255-261, 2011.
[5]
F.C. Liu, L.F. Hung, W.L. Wu, D.M. Chang, C.Y. Huang, J.H. Lai, and L.J. Ho, "Chondroprotective effects and mechanisms of resveratrol in advanced glycation end products stimulated chondrocytes", Arthritis Res. Ther., vol. 12, p. R167, 2011.
[6]
H. Hanai, T. Iida, K. Takeuchi, F. Watanabe, Y. Maruyama, and A. Andoh, "Curcumin maintenance therapy for ulcerative colitis: Randomized, multicenter, double-blind, placebo-controlled trial", Clin. Gastroenterol. Hepatol., vol. 4, pp. 1502-1506, 2006.
[7]
J. Shaikh, D.D. Ankola, V. Beniwal, D. Singh, and M.N. Kumar, "Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer", Eur. J. Pharm. Sci., vol. 37, pp. 223-230, 2009.
[8]
E. Wenzel, and V. Somoza, "Metabolism and bioavailability of trans-resveratrol", Mol. Nutr. Food Res., vol. 49, pp. 472-481, 2005.
[9]
A. Amri, J.C. Chaumeil, S. Sfar, and C. Charrueau, "Administration of resveratrol: What formulation solutions to bioavailability limitations?", J. Control. Release, vol. 158, pp. 182-193, 2012.
[10]
C. Morand, V. Crespy, C. Manach, C. Besson, C. Demigné, and C. Rémésy, "Plasma metabolites of quercetin and their antioxidant properties", Am. J. Physiol., vol. 275, pp. R212-R219, 1998.
[11]
S. Huang, and W.H. Chang, "Advantages of nanotechnology-based Chinese herb drugs on biological activities", Curr. Drug Metab., vol. 10, pp. 905-913, 2009.
[12]
M. Rahman, S. Beg, A. Verma, F.A. Al Abbasi, F. Anwar, S. Saini, S. Akhter, and V. Kumar, "Phytoconstituents as pharmacotherapeutics in rheumatoid arthritis: Challenges and scope of nano/submicromedicine in its effective delivery", J. Pharm. Pharmacol., vol. 69, no. 1, pp. 1-14, 2017.
[13]
P. Pandey, M. Rahman, P.C. Bhatt, S. Beg, B. Paul, A. Hafeez, F.A. Al-Abbasi, M.S. Nadeem, O. Baothman, F. Anwar, and V. Kumar, "Implication of nano-antioxidant therapy for treatment of hepatocellular carcinoma using PLGA nanoparticles of rutin", Nanomedicine (Lond.), vol. 13, no. 8, pp. 849-870, 2018.
[14]
V. Kumar, P.C. Bhatt, M. Rahman, G. Kaithwas, H. Choudhry, F.A. Al-Abbasi, F. Anwar, and A. Verma, "Fabrication, optimization, and characterization of umbelliferone β-D-galactopyranoside-loaded PLGA nanoparticles in treatment of hepatocellular carcinoma: In vitro and in vivo studies", Int. J. Nanomedicine, vol. 12, pp. 6747-6758, 2017.

© 2022 Bentham Science Publishers | Privacy Policy